Payment overview · 2025
General Payments
$197.56
3 reported records · 2 companies
Healthcare provider profile · identity verified
Jay S Friedman, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · SCOTTSDALE, AZ · NPI 1821163825
Verified facts
What the public records show
CMS Open Payments records show Jay S Friedman, M.D. received $197.56 in general payments during 2025 across 3 reported records.
INTUITIVE SURGICAL, INC. accounted for 66.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| INTUITIVE SURGICAL, INC. | Unresolved — no canonical attribution shown | $130.73 | 66.2% | 1 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$66.83 | 33.8% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $197.56 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Da Vinci Surgical System Normalized: da vinci surgical system |
Device | INTUITIVE SURGICAL, INC. | $130.73 | 1 | 2025 |
Source payment records
|
|||||
| INCEPTIV Normalized: inceptiv |
Device | Medtronic, Inc. | $35.17 | 1 | 2025 |
Source payment records
|
|||||
| INTELLIS ADAPTIVESTIM Normalized: intellis adaptivestim |
Device | Medtronic, Inc. | $31.66 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 1282 | 353 |
| Atorvastatin Calcium | Atorvastatin Calcium | 936 | 244 |
| Levothyroxine Sodium | Levothyroxine Sodium | 900 | 242 |
| Losartan Potassium | Losartan Potassium | 824 | 214 |
| Amlodipine Besylate | Amlodipine Besylate | 777 | 203 |
| Lisinopril | Lisinopril | 477 | 123 |
| Tamsulosin Hcl | Tamsulosin Hcl | 345 | 97 |
| Metformin Hcl | Metformin Hcl | 326 | 93 |
| Escitalopram Oxalate | Escitalopram Oxalate | 286 | 79 |
| Trazodone Hcl | Trazodone Hcl | 274 | 79 |
| Eliquis | Apixaban | 243 | 57 |
| Ozempic | Semaglutide | 237 | 44 |
| Allopurinol | Allopurinol | 223 | 59 |
| Pantoprazole Sodium | Pantoprazole Sodium | 207 | 57 |
| Ezetimibe | Ezetimibe | 202 | 57 |
| Simvastatin | Simvastatin | 193 | 51 |
| Finasteride | Finasteride | 192 | 48 |
| Omeprazole | Omeprazole | 190 | 52 |
| Gabapentin | Gabapentin | 185 | 65 |
| Metoprolol Succinate | Metoprolol Succinate | 180 | 49 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 165 | 44 |
| Spironolactone | Spironolactone | 163 | 46 |
| Celecoxib | Celecoxib | 150 | 63 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 145 | 36 |
| Metformin Hcl Er | Metformin Hcl | 142 | 45 |
| Nebivolol Hcl | Nebivolol Hcl | 139 | 33 |
| Hydrochlorothiazide | Hydrochlorothiazide | 138 | 36 |
| Zolpidem Tartrate | Zolpidem Tartrate | 129 | 39 |
| Azithromycin | Azithromycin | 127 | 106 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 126 | 35 |
| Sertraline Hcl | Sertraline Hcl | 118 | 31 |
| Furosemide | Furosemide | 116 | 36 |
| Clopidogrel | Clopidogrel Bisulfate | 110 | 34 |
| Xarelto | Rivaroxaban | 104 | 21 |
| Clonazepam | Clonazepam | 98 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 95 | 22 |
| Synthroid | Levothyroxine Sodium | 93 | 29 |
| Potassium Chloride | Potassium Chloride | 90 | 29 |
| Valacyclovir | Valacyclovir Hcl | 90 | 36 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 89 | 25 |
| Cephalexin | Cephalexin | 87 | 60 |
| Carvedilol | Carvedilol | 86 | 28 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 85 | 85 |
| Donepezil Hcl | Donepezil Hcl | 83 | 17 |
| Montelukast Sodium | Montelukast Sodium | 76 | 23 |
| Januvia | Sitagliptin Phosphate | 74 | 19 |
| Famotidine | Famotidine | 69 | 30 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 68 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 68 | 19 |
| Atenolol | Atenolol | 67 | 17 |
| Bupropion Xl | Bupropion Hcl | 67 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 67 | 28 |
| Memantine Hcl | Memantine Hcl | 66 | 14 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 65 | 14 |
| Benazepril Hcl | Benazepril Hcl | 65 | 15 |
| Farxiga | Dapagliflozin Propanediol | 65 | 15 |
| Paxlovid | Nirmatrelvir/Ritonavir | 64 | 64 |
| Repatha Sureclick | Evolocumab | 64 | suppressed |
| Lorazepam | Lorazepam | 62 | 16 |
| Estradiol | Estradiol | 60 | 18 |
| Metoprolol Tartrate | Metoprolol Tartrate | 59 | 20 |
| Myrbetriq | Mirabegron | 59 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 55 | 17 |
| Prednisone | Prednisone | 55 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 54 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 51 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 51 | 12 |
| Valsartan | Valsartan | 50 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 49 | suppressed |
| Testosterone | Testosterone | 49 | 15 |
| Gemtesa | Vibegron | 47 | suppressed |
| Jardiance | Empagliflozin | 47 | 12 |
| Mounjaro | Tirzepatide | 46 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 45 | 12 |
| Acyclovir | Acyclovir | 44 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 44 | suppressed |
| Nifedipine Er | Nifedipine | 44 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 44 | 18 |
| Estradiol (Twice Weekly) | Estradiol | 40 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 36 | suppressed |
| Colchicine | Colchicine | 36 | 21 |
| Ramipril | Ramipril | 36 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 35 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 33 | 12 |
| Propranolol Hcl Er | Propranolol Hcl | 33 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 32 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 31 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 31 | suppressed |
| Hydrocortisone | Hydrocortisone | 30 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 30 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 29 | 23 |
| Primidone | Primidone | 29 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Ondansetron Odt | Ondansetron | 28 | 18 |
| Diazepam | Diazepam | 27 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 27 | suppressed |
| Lansoprazole | Lansoprazole | 27 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 23 |
| Levofloxacin | Levofloxacin | 26 | 22 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 25 | 23 |
| Tresiba Flextouch U-100 | Insulin Degludec | 25 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 24 | suppressed |
| Methylprednisolone | Methylprednisolone | 24 | 22 |
| Cefuroxime | Cefuroxime Axetil | 23 | 21 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 23 | suppressed |
| Nadolol | Nadolol | 23 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 23 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 22 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 22 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 18 |
| Chlorthalidone | Chlorthalidone | 21 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 21 | suppressed |
| Glimepiride | Glimepiride | 21 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Telmisartan | Telmisartan | 21 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 20 | suppressed |
| Alprazolam | Alprazolam | 19 | 11 |
| Calcitriol | Calcitriol | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 19 | suppressed |
| Progesterone | Progesterone, Micronized | 19 | suppressed |
| Trandolapril | Trandolapril | 19 | suppressed |
| Vascepa | Icosapent Ethyl | 19 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Irbesartan | Irbesartan | 17 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Torsemide | Torsemide | 17 | suppressed |
| Dutasteride | Dutasteride | 16 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 16 | suppressed |
| Mirtazapine | Mirtazapine | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Brilinta | Ticagrelor | 15 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 15 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 15 | suppressed |
| Scopolamine | Scopolamine | 15 | 14 |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 14 | 14 |
| Bumetanide | Bumetanide | 14 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 14 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Lyllana | Estradiol | 14 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 14 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 14 | suppressed |
| Yuvafem | Estradiol | 14 | suppressed |
| Atovaquone-Proguanil Hcl | Atovaquone/Proguanil Hcl | 13 | 12 |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 13 | 13 |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 13 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Dayvigo | Lemborexant | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 12 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Meloxicam | Meloxicam | 12 | suppressed |
| Ofloxacin | Ofloxacin | 12 | 11 |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Rivastigmine | Rivastigmine | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $197.56 · 3 records | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System, INCEPTIV, INTELLIS ADAPTIVESTIM | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error